You are using an outdated browser. Please upgrade your browser to improve your experience.

hepatoencephalopathy due to combined oxidative phosphorylation defect type 1

Disease Summary
Associated Targets (1)
Tbio

1


Mondo Description Hepatoencephalopathy due to combined oxidative phosphorylation deficiency type 1 is a rare, inherited mitochondrial disorder due to a defect in mitochondrial protein synthesis characterized by intrauterine growth retardation, metabolic decompensation with recurrent vomiting, persistent severe lactic acidosis, encephalopathy, seizures, failure to thrive, severe global developmental delay, poor eye contact, severe muscular hypotonia or axial hypotonia with limb hypertonia, hepatomegaly and/or liver dysfunction and/or liver failure, leading to fatal outcome in severe cases. Neuroimaging abnormalities may include corpus callosum thinning, leukodystrophy, delayed myelination and basal ganglia involvement.
Uniprot Description A mitochondrial disease resulting in early rapidly progressive hepatoencephalopathy.
Mondo Term and Equivalent IDs
MONDO:0012191:  hepatoencephalopathy due to combined oxidative phosphorylation defect type 1
DOID:0111474: 
MESH:C563797: 
NCIT:C125663: 
Orphanet:137681: 
SCTID:764962002: 
UMLS:C1836797: